No abstract available
Publication types
-
Case Reports
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adalimumab
-
Adrenal Cortex Hormones / therapeutic use
-
Adult
-
Alefacept
-
Anti-Inflammatory Agents / adverse effects*
-
Anti-Inflammatory Agents / therapeutic use
-
Antibodies, Monoclonal / therapeutic use
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Antirheumatic Agents / adverse effects*
-
Antirheumatic Agents / therapeutic use
-
Arthritis, Rheumatoid / drug therapy
-
Crohn Disease / drug therapy
-
Cyclosporine / therapeutic use
-
Etanercept
-
Female
-
Humans
-
Immunoglobulin G / adverse effects*
-
Immunoglobulin G / therapeutic use
-
Methotrexate / therapeutic use
-
Middle Aged
-
Mycophenolic Acid / analogs & derivatives
-
Mycophenolic Acid / therapeutic use
-
PUVA Therapy
-
Psoriasis / drug therapy*
-
Psoriasis / etiology*
-
Receptors, Tumor Necrosis Factor / therapeutic use
-
Recombinant Fusion Proteins / therapeutic use
-
Treatment Outcome
-
Ustekinumab
Substances
-
Adrenal Cortex Hormones
-
Anti-Inflammatory Agents
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antirheumatic Agents
-
Immunoglobulin G
-
Receptors, Tumor Necrosis Factor
-
Recombinant Fusion Proteins
-
Cyclosporine
-
Alefacept
-
Ustekinumab
-
Adalimumab
-
Mycophenolic Acid
-
Etanercept
-
efalizumab
-
Methotrexate